In osteosarcoma, increased expression of Wnt ligands and receptors, as well as genetic alterations in key pathway components, such as β-catenin and APC, can result in the stabilization and nuclear translocation of β-catenin, promoting the transcription of target genes associated with cell proliferation and survival [30, 31]. This evidence concerns the gene APC and osteosarcoma.